Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction.

Source:http://linkedlifedata.com/resource/pubmed/id/18292296

Download in:

View as

General Info

PMID
18292296